Literature DB >> 20533554

Solid-state forms of zoledronic acid: polymorphism in hydrates.

Romina Ruscica1, Micaela Bianchi, Mariano Quintero, Andrea Martinez, Daniel R Vega.   

Abstract

Solid-state forms of zoledronic acid, a nitrogen-containing bisphosphonate used for treatment of bone diseases are studied using different experimental techniques (DSC, TG, and XRD). Two degrees of hydration have been obtained, containing one and three water molecules per zoledronic acid molecule. The crystal structure of the trihydrated form is reported. Two different anhydrated forms have been obtained when the hydrated ones were heated. Besides, during the dehydration process, an amount of metastable amorphous phase appears, as a function of the dehydration rate. The stability of the obtained crystalline forms is examined under high humidity and a different trihydrated form was obtained, setting clear that the same degree of hydration (trihydrated) can be obtained in two different crystalline forms, and then very different thermal behaviors have been observed.
© 2010 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20533554     DOI: 10.1002/jps.22223

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Solvent effect on molecular structure, IR spectra, thermodynamic properties and chemical stability of zoledronic acid: DFT study.

Authors:  Qingzhu Liu; Ling Qiu; Yang Wang; Gaochao Lv; Guiqing Liu; Shanshan Wang; Jianguo Lin
Journal:  J Mol Model       Date:  2016-03-18       Impact factor: 1.810

2.  Density functional theory studies on a non-covalent interaction system: hydrogen-bonded dimers of zoledronate.

Authors:  Qingzhu Liu; Ke Li; Gaochao Lv; Xi Li; Ying Peng; Jianguo Lin; Ling Qiu
Journal:  J Mol Model       Date:  2018-10-09       Impact factor: 1.810

3.  Tris(dicyclo-hexyl-ammonium) hydrogen [1-hy-droxy-2-(1H-imidazol-1-yl)-1-phospho-natoethane]-phospho-nate ethanol monosolvate mono-hydrate.

Authors:  Anindita Sarkar; Ignacy Cukrowski
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-10-22

4.  Drug-Inclusive Inorganic-Organic Hybrid Systems for the Controlled Release of the Osteoporosis Drug Zoledronate.

Authors:  Maria Vassaki; Savvina Lazarou; Petri Turhanen; Duane Choquesillo-Lazarte; Konstantinos D Demadis
Journal:  Molecules       Date:  2022-09-21       Impact factor: 4.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.